FRANKFURT, Dec 5 (Reuters) - Australian cannabis grower
Little Green Pharma is planning a Frankfurt stock market listing
to reap proceeds for expansion in its largest European market
for medicinal pot, people close to the matter said.
The company is working with Goldman Sachs GS.N and
Deutsche Bank DBKGn.DE as so-called global coordinators of the
initial public offering, which may take place in the second
quarter of 2019 and would make it the first pot producer stock
in Germany, the people said.
Little Green Pharma and the banks declined to comment.
(Reporting by Arno Schuetze; editing by Thomas Seythal)
((arno.schuetze@thomsonreuters.com; +49.69.7565.1197; Reuters
Messaging: arno.schuetze.reuters.com@reuters.net))